Molecular Diagnostics Korea
Molecular Diagnostics Korea (MDxK) is a South Korean life sciences distributor that sells and supports instruments, reagents, and consumables from 30+ international brands across multiomics, cellular biology, structural biology, and biobanking for domestic research institutions and laboratories.
- Company typePrivate
- Founded2018
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Molecular Diagnostics Korea does
Molecular Diagnostics Korea (MDxK, (주)엠디엑스케이) is a South Korean life sciences distributor headquartered in Gwacheon-si, Gyeonggi Province, that operates as an Application-centered Total Solution Provider for the domestic research market. Established in 2018 and led by CEO Shim Seong-bo, the company employs between 11 and 50 people and distributes instruments, reagents, and consumables from more than 30 international brands across four core application areas: Multiomics & Molecular Biology (PacBio HiFi sequencing, Bionano optical genome mapping, Vizgen MERSCOPE spatial genomics, Mission Bio Tapestri, Olink proximity extension assays, Parse Biosciences, CleanNA, highQu, seqWell, Bioskryb); Biologics & Cellular Biology (Bruker Cellular Analysis Beacon, INDICA Labs RNAscope, Navinci Diagnostics PLA assays, SPT Labtech); Crystallography & Structural Biology (Molecular Dimensions, NeXtal, Anatrace, Rigaku Reagents, MiteGen, Excel Scientific); and Bio-banking & Sample Management (Micronic 2D-coded tubes and Tracxer readers, BioMicroLab robotics, NovoSanis Colli-Pee).
MDxK generates revenue through authorized-distribution and resale agreements with international manufacturers, with no publicly disclosed pricing and a quote-based direct-sales motion supported by online inquiry, field-application support, webinars, conference participation (KOGO, KSBMB), and grant programs such as PacBio SMRT Grants. The customer base is concentrated in Korean research institutions, universities, and laboratories, with named touchpoints including Seoul National University NICEM, DNA Link, and Macrogen as PacBio certified service providers. The principal relationship mix carries notable turnover risk: the company ended its 2013-vintage ACD (Advanced Cell Diagnostics) distribution agreement in September 2025, while signing a new distribution deal with Pixelgen Technologies for the Proxiome spatial proteomics kit in December 2025.
There is no public listing, no disclosed external funding, no parent company, and no subsidiary structure. The competitive position rests on the breadth of its OEM portfolio and local field-application expertise rather than proprietary technology or AI capabilities.
Molecular Diagnostics Korea firmographics
Firmographics- Name
- Molecular Diagnostics Korea
- Legal name
- (주)엠디엑스케이
- Website
- https://mdxk.co.kr
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Molecular Diagnostics Korea (MDxK) is a South Korean life sciences distributor that sells and supports instruments, reagents, and consumables from 30+ international brands across multiomics, cellular biology, structural biology, and biobanking for domestic research institutions and laboratories.
- Ownership category
- akta.pro rank
Where Molecular Diagnostics Korea is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Molecular Diagnostics Korea business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Product Distribution: MDxK generates revenue by distributing and reselling life science instruments, reagents, and consumables from international manufacturers to research institutions and laboratories in South Korea. The company acts as an authorized distributor for multiple brands including PacBio, Vizgen, Olink, Bionano Genomics, Bruker Cellular Analysis, and others.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Direct sales through online inquiry system |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Molecular Diagnostics Korea product offering
Product offeringCore offering
MDxK is an Application-centered Total Solution Provider that distributes and supports life science instruments, reagents, and consumables from over 30 international manufacturers (including PacBio, Bionano Genomics, Vizgen, Olink, Bruker Cellular Analysis, Mission Bio, Parse Biosciences, and Micronic) to research institutions and laboratories in South Korea. The portfolio spans four application areas: Multiomics & Molecular Biology, Biologics & Cellular Biology, Crystallography & Structural Biology, and Bio-banking & Sample Management, supplemented by professional field support, webinars, and grant programs for Korean researchers.
Product overview
MDxK ((주)엠디엑스케이) is an Application-focused Total Solution Provider for the Korean life science research community, distributing and supporting a comprehensive portfolio of international brands across four core application areas. In Multiomics & Molecular Biology, MDxK represents PacBio (HiFi long-read sequencing), Bionano Genomics (optical genome mapping), Vizgen MERSCOPE (spatial genomics/MERFISH), Mission Bio Tapestri (single-cell DNA), Olink (proteomics/PEA), Parse Biosciences (single-cell RNA), seqWell (library prep), and CleanNA/highQu (nucleic acid tools). In Biologics & Cellular Biology, the portfolio includes Bruker Cellular Analysis Beacon (single-cell screening), INDICA Labs/RNAscope (spatial RNA detection), and Navinci Diagnostics (protein interaction assays). For Structural Biology, MDxK supplies Molecular Dimensions and NeXtal (crystallization screens), Rigaku Reagents, MiteGen, Excel Scientific (sealing films), and SPT Labtech. In Bio-banking & Sample Management, the offering centers on Micronic (2D-coded sample storage tubes, racks, and automated readers), BioMicroLab, and NovoSanis (specialized collection devices). This multi-brand distribution model enables end-to-end support from basic research through clinical and pharmaceutical applications.
Differentiator
Problem solved
Functional benefit
Products and services
- PacBio Sequencing Systems (Sequel II/IIe) PacBio Sequel II/IIe systems for HiFi long-read sequencing, enabling applications in genomics, metagenomics, rare disease research, and structural variant detection. Sold to genomics researchers in South Korea.
- Bionano Genomics Saphyr Optical genome mapping platform for comprehensive structural variant detection across the entire genome without sequencing-based limitations. For genomics researchers and cytogeneticists.
- Vizgen MERSCOPE Spatial genomics platform using MERFISH technology for highly multiplexed RNA profiling with sub-cellular resolution in intact tissue context. For spatial biology researchers.
- Mission Bio Tapestri Single-cell DNA sequencing platform for simultaneous genotyping and phenotyping analysis of heterogeneous cell populations. For oncology and cell population heterogeneity research.
- Olink Proteomics Platforms Proximity Extension Assay (PEA) technology for high-throughput, multiplexed protein biomarker analysis via Olink Insight, Reveal, and Focus platforms. For proteomics and biomarker researchers.
- CleanNA Nucleic Acid Extraction Reagents Magnetic bead-based nucleic acid extraction and purification reagents for molecular biology applications. For molecular biology laboratories.
- highQu PCR and NGS Reagents High-purity enzymes and reagents for PCR, qPCR, and next-generation sequencing library preparation. For molecular biology and sequencing laboratories.
- Parse Biosciences Single-Cell RNA Sequencing Split-pool combinatorial barcoding technology for single-cell RNA sequencing, including the Chromium-compatible portfolio and new Penta kit for 5 million cell analysis. For single-cell transcriptomics researchers.
- Bruker Cellular Analysis Beacon Optofluidic platform for single-cell screening, selection, and characterization supporting antibody discovery, cell line development, and T cell profiling workflows. For biologics researchers and antibody discovery teams.
- seqWell ExpressPlex Library Prep Kit Tn5 transposase-based library preparation kit enabling 30-minute hands-on time and 100-minute total protocol for rapid, high-quality NGS library construction. For genomics and sequencing laboratories.
- Micronic Sample Storage Solutions 2D Data-Matrix coded sample storage tubes, racks, and automated readers for biobanking and sample management, including External Thread, Internal Thread, and Hybrid tube lines. For biobanks and research sample repositories.
- Molecular Dimensions Crystallization Products Screen, reagent, consumable, and instrument products for protein crystallization, including BCS screen, MIDASplus, and other structural biology solutions. For structural biology and crystallography researchers.
- NeXtal Biotechnologies Crystallization Screens Protein crystallization screens, plates, and accessories including DWBlock, Classics Suite, JCSG+ Suite, and other screening kits for structural biology research. For protein crystallography researchers.
- Rigaku Reagents Crystallography Kits
Companies that use Molecular Diagnostics Korea
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles2 records
Molecular Diagnostics Korea technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature1 record
Molecular Diagnostics Korea partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Pixelgen TechnologiescorePixelgen Technologies signed a distribution agreement with Molecular Diagnostics Korea (MDxK) for its Proxiome protein analysis kit in South Korea. This marks an expansion of Pixelgen's distribution network in Asia. MDxK will distribute Pixelgen's Proxiome product to Korean researchers.
Scale indicators1 record
Recent moves4 records
Expansion highlights4 records
Molecular Diagnostics Korea competitors and assessment
Company assessmentRegional players
- Filgen: Filgen distributes life science instruments, reagents, and bio-informatics tools from international manufacturers to Japanese research institutions, mirroring MDxK's Total Solution Provider approach in an adjacent Asian market.
- Gene Company Limited: Gene Company distributes advanced life science research tools (including genomics, proteomics, and cell biology platforms) across Asia from global principals, providing a comparable multi-brand distribution model in the broader Asian region.
- Cosmo Bio: Cosmo Bio is a major Japanese life science distributor offering reagents, instruments, and consumables from global principals to research customers — a regional peer with a comparable authorized-distributor business model to MDxK's.
- Axil Scientific: Axil Scientific distributes life science research products and instruments across Southeast Asia from international manufacturers, comparable to MDxK as an Asia-focused life science channel partner.
Broad incumbents
- Bio-Techne: Bio-Techne is a large global life science tools provider whose reagents and proteomics kits (including the ProteinSimple and ExoDx brands) compete with several of the principals MDxK distributes, while also operating direct sales channels that could disintermediate distributors like MDxK.
- Thermo Fisher Scientific: Thermo Fisher supplies analytical instruments, reagents, and lab services globally (including via its Life Sciences Solutions segment) and sells directly into Korea, representing both competitive overlap with MDxK's principals and a risk of direct disintermediation.
- PerkinElmer (Revvity): Revvity (formerly PerkinElmer) sells life science instruments, reagents, and software (including spatial biology and genomics tools) into the Korean market via direct channels, representing a broad incumbent that competes with MDxK's distributed portfolio.
- Danaher (Beckman Coulter, Cytiva, Leica): Danaher's life sciences subsidiaries (Beckman Coulter, Cytiva, Leica Biosystems, IDT) overlap heavily with MDxK's distributed brands and increasingly run direct regional sales teams that compete with or bypass local distributors.
Direct peers
- Bio-Medical Science Co., Ltd. Bio-Medical Science is a Korean distributor of life science research instruments, reagents, and consumables serving universities and biotech labs in Korea, overlapping closely with MDxK's multiomics and cellular biology portfolio.
- KAINOS: KAINOS is a Korean life science distributor representing a portfolio of international research tools and reagents to Korean academic and pharma customers, directly comparable to MDxK's application-centered distribution model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Molecular Diagnostics Korea social profiles
Digital presenceMolecular Diagnostics Korea financial estimates
Financial estimateRevenue estimate
Valuation estimate
Molecular Diagnostics Korea leadership team
Management profileNumber of profiles
Profiles2 records
Molecular Diagnostics Korea funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Molecular Diagnostics Korea M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Molecular Diagnostics Korea
What does Molecular Diagnostics Korea do?
MDxK is an Application-centered Total Solution Provider that distributes and supports life science instruments, reagents, and consumables from over 30 international manufacturers (including PacBio, Bionano Genomics, Vizgen, Olink, Bruker Cellular Analysis, Mission Bio, Parse Biosciences, and Micronic) to research institutions and laboratories in South Korea. The portfolio spans four application areas: Multiomics & Molecular Biology, Biologics & Cellular Biology, Crystallography & Structural Biology, and Bio-banking & Sample Management, supplemented by professional field support, webinars, and grant programs for Korean researchers.
Is Molecular Diagnostics Korea a public or private company?
Molecular Diagnostics Korea is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Molecular Diagnostics Korea founded?
Molecular Diagnostics Korea was founded in 2018. It employs 11 to 50 people.
Where is Molecular Diagnostics Korea based?
Molecular Diagnostics Korea is headquartered in Seoul, South Korea, in the Asia region.
How does Molecular Diagnostics Korea make money?
One revenue line is on record: product Distribution.
Who are Molecular Diagnostics Korea's main competitors?
Regional players on record are Filgen, Gene Company Limited, Cosmo Bio and Axil Scientific. Broad incumbents are Bio-Techne, Thermo Fisher Scientific, PerkinElmer (Revvity) and Danaher (Beckman Coulter, Cytiva, Leica). Direct peers are Bio-Medical Science Co., Ltd. and KAINOS.
Does Molecular Diagnostics Korea have an API?
No public API is recorded for Molecular Diagnostics Korea.